Page 1115 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

30. Josko D. Yersinia pestis: still a plague in the 21st century. Clin 45. Slater PE, Anis E, Leventhal A. Preparation for an outbreak of
Lab Sci. 2004;17:25-29. smallpox in Israel. Isr Med Assoc J. 2002;4:507-512.
31. Rollins SE, Rollins SM, Ryan ET. Yersinia pestis and the plague. 46. Emergency preparedness and response: smallpox: medi-
Am J Clin Pathol. 2003;119(suppl):S78-S85. cal management. Atlanta: Centers for Disease Control and
32. Wong D, Wild MA, Walburger MA, et al. Primary pneumonic Prevention; 2010. http://www.bt.cdc.gov/agent/smallpox/
plague contracted from a mountain lion carcass. Clin Infect Dis. medical-management/
2009;49:e33-e38. 47. Berger SA, Shapira I. Hemorrhagic fevers and bioterror. Isr Med
33. Plague manual: epidemiology, distribution, surveillance and Assoc J. 2002;4:513-519.
control: World Health Organization; 2010. http://www.who.int/ 48. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses
csr/resources/publications/plague/WHO_CDS_CSR_EDC_99 as biological weapons: medical and public health management.
https://kat.cr/user/tahir99/
_2_EN/en/ JAMA. 2002;287:2391-2405.
34. Emergency preparedness and response: Tularemia. Altanta: 49. Emergency preparedness and response: viral hemorrahgic
Centers for Disease Control and Prevention; 2010. http://www fevers. Atlanta: Centers for Disease Control and Prevention;
.bt.cdc.gov/agent/tularemia/ 2010. http://www.bt.cdc.gov/agent/vhf/
35. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as 50. Yellow Fever. Atlanta: Centers for Disease Control and
a biological weapon: medical and public health management. Prevention; 2010. http://www.cdc.gov/ncidod/dvbid/
JAMA. 2001;285:2763-2773. yellowfever/index.html
36. Thomas LD, Schaffner W. Tularemia pneumonia. Infect Dis Clin 51. Category B Agents. Atlanta: Centers for Disease Control
North Am. 2010;24:43-55. and Prevention; 2010. http://www.bt.cdc.gov/agent/agentlist-
37. Emergency preparedness and response: botulism: Centers for category.asp#b
Disease Control and Prevention; 2010. http://www.bt.cdc.gov/ 52. Gikas A, Kokkini S, Tsioutis C. Q fever: clinical manifestations
agent/botulism/ and treatment. Expert Rev Anti Infect Ther. 2010;8:529-539.
38. Osborne SL, Latham CF, Wen PJ, et al. The Janus faces of botu- 53. Moran GJ. Threats in bioterrorism. II: CDC category B and C
linum neurotoxin: sensational medicine and deadly biological agents. Emerg Med Clin North Am. 2002;20:311-330.
weapon. J Neurosci Res. 2007;85:1149-1158. 54. Marks JD. Medical aspects of biologic toxins. Anesthesiol Clin
39. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as North America. 2004;22:509-532, vii.
a biological weapon: medical and public health management. 55. Fact- sheet: Western equine encephalitis. Atlanta: Centers for
JAMA. 2001;285:1059-1070. Disease Control and Prevention; 2010. http://www.cdc.gov/
40. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox ncidod/dvbid/arbor/weefact.htm
as a biological weapon: medical and public health manage- 56. Arboviral encephalitidies. Atlanta: Centers for Disease Control
ment. Working Group on Civilian Biodefense. JAMA. and Prevention; 2010. http://www.cdc.gov/ncidod/dvbid/arbor/
1999;281:2127-2137. arbdet.htm
41. Emergency preparedness and response: smallpox. Atlanta: 57. Eastern Equine Encephalitis. Atlanta: Center for Disease
Centers for Disease Control and Prevention; 2010. http:// Control and Prevention; 2010. http://www.cdc.gov/
emergency.cdc.gov/agent/smallpox/index.asp EasternEquineEncephalitis/
42. Smallpox. Geneva: World Health Organization; 2010. http:// 58. Roccaforte JD, Cushman JG. Disaster preparation and man-
www.who.int/mediacentre/factsheets/smallpox/en/index.html agement for the intensive care unit. Curr Opin Crit Care.
43. Monkeypox. Atlanta: Center for Disease Control and Prevention; 2002;8:607-615.
2010. http://www.cdc.gov/ncidod/monkeypox/
44. Meltzer MI, Damon I, LeDuc JW, Millar JD. Modeling potential
responses to smallpox as a bioterrorist weapon. Emerg Infect
Dis. 2001;7:959-969.

Section05-O-ref.indd 2 1/20/2015 4:51:26 PM